Virginia S. Hahn

Virginia S. Hahn

Cardiology

4924 Campbell Boulevard, Suite 110
Suite 110
Nottingham, MD 21236

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation.

Myeloid Cell Expansion Propels Right Ventricular Dysfunction in HFpEF Through Sterile Inflammation.

Journal: Circulation

Published: August 18, 2026

Single-Cell Analysis of Human Heart Failure With Preserved Ejection Fraction.

Single-Cell Analysis of Human Heart Failure With Preserved Ejection Fraction.

Journal: Circulation research

Published: May 15, 2026

Senescence and DNA Damage-Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome.

Senescence and DNA Damage-Induced Inflammation Drive Heart Failure with Preserved Ejection Fraction in Cardiovascular Kidney Metabolic Syndrome.

Journal: bioRxiv : the preprint server for biology

Published: April 27, 2026

Severe obesity in human HFpEF alters contractile protein function and organization.

Severe obesity in human HFpEF alters contractile protein function and organization.

Journal: Science (New York, N.Y.)

Published: April 23, 2026

Multicenter HFpEF study identifies sex disparity linked with two discrete cardiac proteomic signatures.

Multicenter HFpEF study identifies sex disparity linked with two discrete cardiac proteomic signatures.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

Myeloid cell recruitment propels right ventricular dysfunction in HFpEF via sterile inflammation.

Myeloid cell recruitment propels right ventricular dysfunction in HFpEF via sterile inflammation.

Journal: bioRxiv : the preprint server for biology

Published: December 03, 2025

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Integrating Pharmacological, Device, and Advanced Heart Failure Therapies.

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Integrating Pharmacological, Device, and Advanced Heart Failure Therapies.

Journal: Journal of cardiac failure

Published: November 08, 2025

Human Immunodeficiency Virus-Associated Proteomic Signature of Myocardial Fibrosis and Incident Heart Failure.

Human Immunodeficiency Virus-Associated Proteomic Signature of Myocardial Fibrosis and Incident Heart Failure.

Journal: The Journal of infectious diseases

Published: September 25, 2025

Looking AHEAD to Heart Failure Prevention: The Role of NT-proBNP and Lifestyle Modification.

Looking AHEAD to Heart Failure Prevention: The Role of NT-proBNP and Lifestyle Modification.

Journal: JACC. Heart failure

Published: September 21, 2025

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Journal: Current treatment options in cardiovascular medicine

Published: August 14, 2025

Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction.

Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction.

Journal: JACC. Advances

Published: August 05, 2025

Circulating monocyte gene expression profiles associated with cardiac remodeling and incident heart failure in the Multi-Ethnic Study of Atherosclerosis.

Circulating monocyte gene expression profiles associated with cardiac remodeling and incident heart failure in the Multi-Ethnic Study of Atherosclerosis.

Journal: Communications medicine

Published: July 10, 2025

Showing 1-12 of 43

Last Updated: 09/26/2026